GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synovics Pharmaceuticals SYVC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2008

Revenue

$26.0m

FY2008FY2008

Net income

−$4.0m

FY2008FY2008

Free cash flow

$3.2m

FY2008FY2008

Shareholders' equity

$5.0m

FY2008FY2008

Income statement

Fiscal years

FY2008
Revenue$26.0m
Gross profit$9.0m
Research and development$1.2m
Operating income−$2.5m
Net income−$4.0m
Diluted earnings per share-0.92

Balance sheet

At each fiscal year end

FY2008
Total assets$22.3m
Total liabilities$17.3m
Debt$5.7m
Shareholders' equity$5.0m
Shares outstanding4m

Cash flow

Fiscal years

FY2008
Cash from operations$3.9m
Capital spending−$708,305
Free cash flow$3.2m

Latest quarters

By quarter end

Jul 2009Apr 2009Jan 2009Oct 2008Jul 2008Apr 2008Jan 2008Oct 2007
Revenue$1.6m$2.8m$6.8m$7.9m$7.7m$6.1m$4.3m$5.3m
Gross profit−$579,759$27,869$2.3m$2.7m————
Operating income−$1.9m−$2.1m−$633,814$265,519————
Net income−$2.0m−$2.6m−$1.1m$670,327$490,000———
Diluted earnings per share-0.46-0.60-0.250.150.11———
Cash from operations———$1.0m$2.0m———
Total assets$18.8m$19.4m$21.8m$22.3m$23.6m$23.9m$21.2m$23.3m
Debt$4.1m$5.2m$5.2m$5.7m$4.6m$4.8m$5.2m$5.6m
Shareholders' equity−$1.6m$511,888$3.2m$4.2m$4.0m———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1368.8%281.8%15.1%
Operating income9.1%—-14.3%
Net income11.2%—-8.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.6%29.9%——
Operating margin-25.8%-30.5%——
Net margin-50.3%-60.6%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%25%0%100%0%900%0%-90%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.